Advances in cancer theranostics using organic-inorganic hybrid nanotechnology

Gang Chen,Yuna Qian,Hang Zhang,Aftab Ullah,Xiaojun He,Zaigang Zhou,Hicham Fenniri,Jianliang Shen

DOI: https://doi.org/10.1016/j.apmt.2021.101003

IF: 8.663

2021-06-01

Applied Materials Today

Abstract:<p>A series of barriers including poor drug solubility, stability, biocompatibility, bioavailability and pharmacokinetics, distribution to normal tissues, hemorheological flow limitations, multidrug resistance (MDR), and metastasis compromise cancer therapeutic effects. Nanotechnologies provide potential solutions to address these problems by taking advantage of distinct mechanisms of action of multiple therapeutics/modalities. In this regard, hybrid nanomaterials hold great promise for tremendous potential applications. In cancer diagnosis and therapy, a combination of the unique physical and chemical properties of two or more classes of nanomaterials can be used to produce versatile new categories of nanomaterials for gene/drug delivery, immunotherapy, molecular diagnostic, and bio-imaging. Such nanoplatforms of hybrid materials expand the functionality of single-component systems by synergistically killing of target tumor tissues and cells. This review will elaborate on current advances in the design/development, biomedical applications, and therapeutic advantages of state-of-the-art organic-inorganic hybrid nanomaterials used in cancer theranostics. We believe that this class of hybrid nanotechnology might provide new prospects for clinical therapy and management of cancer.</p>

materials science, multidisciplinary